Palatin Technologies, Inc(NYSE MKT:PTN) 
Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acqui...
Website: http://www.palatin.com
Founded: 1986
Full Time Employees: 20
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-11-05
P
O 1.20
H 1.23
L 1.15
C 1.18
V 121,989
10EMA 1.18
20EMA 1.18
60EMA 1.18
120EMA 1.18
250EMA 1.18